IDEXX Labs (NASDAQ: IDXX) reported Q4 EPS of $0.48, $0.04 better than the analyst estimate of $0.44. Revenue for the quarter came in at $400 million versus the consensus estimate of $397.39 million.

GUIDANCE:

IDEXX Labs sees FY2016 EPS of $2.10-$2.17, versus the consensus of $2.13. IDEXX Labs sees FY2016 revenue of $1.69-1.71 billion, versus the consensus of $1.71 billion.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.